BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 36176912)

  • 1. Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.
    Wang X; Hua P; He C; Chen M
    Acta Pharm Sin B; 2022 Sep; 12(9):3567-3593. PubMed ID: 36176912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
    Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
    Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
    Gao W; Wang X; Zhou Y; Wang X; Yu Y
    Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.
    Yin W; Chang J; Sun J; Zhang T; Zhao Y; Li Y; Dong H
    J Mater Chem B; 2023 Feb; 11(6):1171-1190. PubMed ID: 36650960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
    Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
    Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook.
    Sepand MR; Ranjbar S; Kempson IM; Akbariani M; Muganda WCA; Müller M; Ghahremani MH; Raoufi M
    Nanomedicine; 2020 Oct; 29():102243. PubMed ID: 32623018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma.
    Dong L; Vargas CPD; Tian X; Chu X; Yin C; Wong A; Yang Y
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis.
    Wendlocha D; Kubina R; Krzykawski K; Mielczarek-Palacz A
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance.
    Chen JW; Chen S; Chen GQ
    Cancer Drug Resist; 2023; 6(4):729-747. PubMed ID: 38239395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.
    Zhang C; Liu N
    Front Immunol; 2022; 13():920059. PubMed ID: 35958626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine-mediated regulated cell death in cancer immunotherapy.
    Sun Y; Lian T; Huang Q; Chang Y; Li Y; Guo X; Kong W; Yang Y; Zhang K; Wang P; Wang X
    J Control Release; 2023 Dec; 364():174-194. PubMed ID: 37871752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting regulated cell death in tumor nanomedicines.
    Zeng Q; Ma X; Song Y; Chen Q; Jiao Q; Zhou L
    Theranostics; 2022; 12(2):817-841. PubMed ID: 34976215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects.
    Yu S; Tong L; Shen J; Li C; Hu Y; Feng K; Shao J
    Eur J Med Chem; 2024 Apr; 269():116290. PubMed ID: 38518522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-apoptotic cell death in ovarian cancer: Treatment, resistance and prognosis.
    Chen J; Wei Z; Fu K; Duan Y; Zhang M; Li K; Guo T; Yin R
    Biomed Pharmacother; 2022 Jun; 150():112929. PubMed ID: 35429741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Apoptotic Cell Death Signaling Pathways in Melanoma.
    Hartman ML
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress on nanomedicine-induced ferroptosis for cancer therapy.
    Zafar H; Raza F; Ma S; Wei Y; Zhang J; Shen Q
    Biomater Sci; 2021 Aug; 9(15):5092-5115. PubMed ID: 34160488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
    Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
    J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury.
    Ning J; Chen L; Zeng Y; Xiao G; Tian W; Wu Q; Tang J; He S; Tanzhu G; Zhou R
    Int J Biol Sci; 2024; 20(5):1871-1883. PubMed ID: 38481804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.